EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor

Marta Opalinska, Luka Lezaic, Clemens Decristoforo, Petra Kolenc, Renata Mikolajczak, Andrej Studen, Urban Simoncic, Irene Virgolini, Malgorzata Trofimiuk-Muldner, Piotr Garnuszek, Christine Rangger, Melpomeni Fani und 3 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2023

DOI: 10.1007/s00259-023-06335-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2023. Verfasst von Marta Opalinska und 14 weiteren Autor:innen. Beteiligte Einrichtung: Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsOrganometallic CompoundsHumansHeterocyclic Compounds, 1-RingSomatostatinReceptors, Somatostatin

Substanzen

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidHeterocyclic Compounds, 1-RingSomatostatinOrganometallic CompoundsReceptors, Somatostatin

Autor:innen und Institutionen

  • Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland.
  • Department of Nuclear Medicine, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Department of Nuclear Medicine, Medical University Innsbruck, Innsbruck, Austria.
  • Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
  • Radioisotope Centre POLATOM, National Centre for Nuclear Research, Otwock, Poland.

ORCID-Profile: Alicja Hubalewska-Dydejczyk

Förderung

  • Austrian Science Fund FWF

Zitieren

APA

Opalinska, M., Lezaic, L., Decristoforo, C., Kolenc, P., Mikolajczak, R., Studen, A., Simoncic, U., Virgolini, I., Trofimiuk-Muldner, M., Garnuszek, P., Rangger, C., Fani, M., Glowa, B., Skorkiewicz, K., & Hubalewska-Dydejczyk, A. (2023). Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06335-9

Vancouver

Opalinska M, Lezaic L, Decristoforo C, Kolenc P, Mikolajczak R, Studen A, et al. Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor. European Journal of Nuclear Medicine and Molecular Imaging. 2023. doi:10.1007/s00259-023-06335-9

BibTeX
@article{Opalinska2023,
  author = {Opalinska, Marta and Lezaic, Luka and Decristoforo, Clemens and Kolenc, Petra and Mikolajczak, Renata and Studen, Andrej and Simoncic, Urban and Virgolini, Irene and Trofimiuk-Muldner, Malgorzata and Garnuszek, Piotr and Rangger, Christine and Fani, Melpomeni and Glowa, Boguslaw and Skorkiewicz, Konrad and Hubalewska-Dydejczyk, Alicja},
  title = {Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2023},
  doi = {10.1007/s00259-023-06335-9}
}
Kostenlos starten →